The chemotherapeutic agent topotecan differentially modulates the phenotype and 
function of dendritic cells

Trojandt, S.; Knies, D.; Pektor, S.; Ritz, Sandra; Mailänder, Volker; Grabbe, S.; Reske-Kunz, A. B.; Bros, M.

doi:10.1007/s00262-013-1431-9

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells

MPS-Authors

/persons/resource/persons79024

Ritz, Sandra
Dept. Landfester: Physical Chemistry of Polymers, MPI for Polymer Research, Max Planck Society;

/persons/resource/persons48370

Mailänder, Volker
Dept. Landfester: Physical Chemistry of Polymers, MPI for Polymer Research, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Trojandt, S., Knies, D., Pektor, S., Ritz, S., Mailänder, V., Grabbe, S., et al. (2013). The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells. Cancer Immunology, Immunotherapy, 62(8), 1315-1326. doi:10.1007/s00262-013-1431-9.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0014-4897-8

Abstract

There is no abstract available